Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

JAZZ

Jazz Pharmaceuticals plc

Oct 03 • 04:00PM ET

108.56

Dollar change -1.14
Percentage change -1.04	%

Healthcare • Biotechnology • Ireland • NASD

Held by: COWZ VTI IJH VB VBR VXF MDY FXH SPMD VHT

Scroll to Statements

Index	-	P/E	19.39	EPS (ttm)	5.60	Insider Own	3.49%	Shs Outstand	62.26M	Perf Week	-1.48%
Market Cap	6.70B	Forward P/E	5.04	EPS next Y	21.55	Insider Trans	-0.30%	Shs Float	59.60M	Perf Month	-0.07%
Income	394.92M	PEG	4.00	EPS next Q	5.52	Inst Own	94.85%	Short Float	5.50%	Perf Quarter	7.20%
Sales	3.91B	P/S	1.71	EPS this Y	6.74%	Inst Trans	-0.78%	Short Ratio	4.81	Perf Half Y	-5.77%
Book/sh	60.94	P/B	1.78	EPS next Y	10.38%	ROA	3.49%	Short Interest	3.28M	Perf Year	-14.46%
Cash/sh	32.08	P/C	3.38	EPS next 5Y	4.85%	ROE	10.84%	52W Range	99.06 - 137.38	Perf YTD	-11.74%
Dividend Est.	-	P/FCF	6.42	EPS past 5Y	-3.53%	ROI	4.42%	52W High	-20.98%	Beta	0.57
Dividend TTM	-	Quick Ratio	1.90	Sales past 5Y	15.52%	Gross Margin	73.60%	52W Low	9.59%	ATR (14)	2.63
Dividend Ex-Date	-	Current Ratio	2.25	EPS Y/Y TTM	546.69%	Oper. Margin	16.63%	RSI (14)	46.07	Volatility	2.40% 2.30%
Employees	2800	Debt/Eq	1.54	Sales Y/Y TTM	3.91%	Profit Margin	10.10%	Recom	1.42	Target Price	178.29
Option/Short	Yes / Yes	LT Debt/Eq	1.37	EPS Q/Q	70.48%	Payout	0.00%	Rel Volume	0.55	Prev Close	109.70
Sales Surprise	1.37%	EPS Surprise	7.68%	Sales Q/Q	6.95%	Earnings	Jul 31 AMC	Avg Volume	681.02K	Price	108.56
SMA20	-0.38%	SMA50	-2.15%	SMA200	-4.97%	Trades		Volume	374,004	Change	-1.04%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-05-24	Initiated	Goldman	Buy	$169
Jan-03-24	Initiated	Robert W. Baird	Outperform	$160
Nov-27-23	Downgrade	UBS	Buy → Neutral	$170 → $135
Sep-29-23	Initiated	Raymond James	Mkt Perform
Jun-12-23	Resumed	Wells Fargo	Equal Weight	$184 → $140
Dec-09-22	Upgrade	Goldman	Neutral → Buy	$192 → $190
Jun-14-22	Initiated	UBS	Buy	$194
Apr-06-22	Downgrade	Goldman	Buy → Neutral	$202 → $196
Nov-19-21	Resumed	Goldman	Buy	$198
Oct-07-21	Resumed	Jefferies	Buy	$172
Oct-05-21	Initiated	Citigroup	Buy	$200
Sep-23-21	Initiated	Needham	Buy	$220
May-19-21	Resumed	JP Morgan	Overweight	$183 → $206
Apr-07-21	Resumed	RBC Capital Mkts	Outperform	$186
Feb-05-21	Reiterated	H.C. Wainwright	Buy	$195 → $207
Feb-03-21	Upgrade	Piper Sandler	Neutral → Overweight	$150 → $175
Jan-29-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Dec-16-20	Initiated	UBS	Buy	$174
Nov-03-20	Reiterated	H.C. Wainwright	Buy	$185 → $195
Oct-09-20	Reiterated	H.C. Wainwright	Buy	$175 → $185

Show Previous Ratings

Today 07:40AM	Jazz Pharmaceuticals plc (JAZZ): Why Are Hedge Funds Bullish On This Cheap Growth Stock Right Now? (Insider Monkey)
Oct-01-24 09:40AM	Is Jazz Pharmaceuticals (JAZZ) Stock Undervalued Right Now? (Zacks)
Sep-16-24 07:30AM	Jazz Pharmaceuticals Presents Updated Phase 2 Data for Zanidatamab Demonstrating Increased mPFS in HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ESMO 2024 (PR Newswire)
Sep-09-24 07:58AM	Jazz Pharmaceuticals to Present Advancements in Solid Tumor Oncology Research at ESMO 2024 (PR Newswire)
Sep-07-24 10:17PM	Jazz Pharmaceuticals plc (JAZZ): Why Do Hedge Funds Recommend This Biotech Stock? (Insider Monkey)
07:30AM	Loading…
Sep-05-24 07:30AM	Jazz Pharmaceuticals to Present New Data Demonstrating Improved Epilepsy Outcomes with Epidiolex/Epidyolex (cannabidiol) at the European Epilepsy Congress 2024 (PR Newswire)
01:07AM	Jazz Pharmaceuticals plc (JAZZ): Among the Best Mid-Cap Healthcare Stocks To Buy Now (Insider Monkey)
Sep-04-24 12:12AM	Jazz Pharmaceuticals Announces Pricing of Private Offering of $850 Million of 3.125% Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases (PR Newswire)
Sep-03-24 07:00AM	Jazz Pharmaceuticals Announces Private Offering of $850 Million of Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases (PR Newswire) -5.74%
Sep-02-24 06:05PM	10 Best Mid-Cap Healthcare Stocks To Buy Now (Insider Monkey)
Aug-30-24 11:31AM	Why Is Jazz (JAZZ) Up 1.1% Since Last Earnings Report? (Zacks)
01:16AM	Jazz Pharmaceuticals plc (JAZZ): Top ADR Stock According to Hedge Funds (Insider Monkey)
Aug-23-24 10:13AM	Jazzs cannabidiol therapy flunks in Japanese Phase III trial (Pharmaceutical Technology)
Aug-22-24 04:05PM	Jazz Pharmaceuticals Provides Update on Cannabidiol Oral Solution Phase 3 Trial in Japan in Treatment-Resistant Epilepsies (PR Newswire)
Aug-21-24 04:15PM	Jazz Pharmaceuticals to Participate in Upcoming September Investor Conferences (PR Newswire)
09:55AM	Loading…
Aug-06-24 09:55AM	Wall Street Analysts Believe Jazz (JAZZ) Could Rally 56.66%: Here's is How to Trade (Zacks)
09:40AM	Is Jazz Pharmaceuticals (JAZZ) a Great Value Stock Right Now? (Zacks)
Aug-05-24 04:06PM	The 3 Best Cannabis Stocks to Buy in August 2024 (InvestorPlace)
09:15AM	Investing in Jazz (JAZZ)? Don't Miss Assessing Its International Revenue Trends (Zacks)
Jul-31-24 10:36PM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research)
05:45PM	Jazz Pharmaceuticals (JAZZ) Beats Q2 Earnings and Revenue Estimates (Zacks)
04:40PM	Jazz: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Jazz Pharmaceuticals Announces Second Quarter 2024 Financial Results and Updates 2024 Financial Guidance (PR Newswire)
Jul-29-24 06:00AM	3 Biotech Stocks to Buy on the Dip: July 2024 (InvestorPlace)
Jul-25-24 04:05PM	Jazz Pharmaceuticals Shareholders Elect Laura Hamill to the Company's Board of Directors at Annual General Meeting (PR Newswire)
Jul-24-24 10:01AM	Jazz Pharmaceuticals (JAZZ) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jul-23-24 03:52AM	Nanotechnology in medicine: Who are the leading public companies? (Medical Device Network)
Jul-22-24 07:45AM	Jazz Pharmaceuticals Announces Successful Completion of Term Loan Repricing and Irrevocable Election of Settlement Method for the 2.000% Exchangeable Senior Notes due 2026 (PR Newswire)
Jul-19-24 01:58PM	If You Can Only Buy One Biotech Stock in July, It Better Be One of These 3 Names (InvestorPlace)
Jul-17-24 04:15PM	Jazz Pharmaceuticals to Report 2024 Second Quarter Financial Results on July 31, 2024 (PR Newswire)
08:30AM	Loading…
Jul-11-24 08:30AM	Is The Options Market Predicting A Spike In JAZZ Pharmaceuticals (JAZZ) Stock? (Zacks)
Jul-09-24 07:45AM	Jazz Pharmaceuticals Promotes Samantha Pearce to Chief Commercial Officer (PR Newswire)
Jul-04-24 08:09AM	3 Mid-Cap Growth Rockets Trading at Deep Discounts to Their Potential (InvestorPlace)
Jul-01-24 12:16AM	Is Jazz Pharmaceuticals plc (JAZZ) the Best Pot Stock to Buy Now? (Insider Monkey)
Jun-26-24 02:11PM	7 Biotech Stocks to Boost Your Portfolio to Peak Health (InvestorPlace)
Jun-25-24 03:39PM	3 Cannabis Stocks That Could Make Your Grandchildren Rich (InvestorPlace)
Jun-21-24 07:00AM	Jazz drug for tremor fails study; Radiopharma drug developer ITM swaps CEOs (BioPharma Dive)
06:33AM	Jazz Pharmaceuticals essential tremor drug falls flat in Phase IIb trial (Clinical Trials Arena)
Jun-20-24 04:08PM	Jazz Dives But Key Rival Praxis Surges On Essential Tremor Drug Failure (Investor's Business Daily)
10:08AM	Jazz Dives And Takes Praxis With It On Essential Tremor Drug Failure (Investor's Business Daily)
07:45AM	Jazz Pharmaceuticals Provides Update on Phase 2b Trial of Investigational Suvecaltamide (JZP385) in Essential Tremor (PR Newswire)
Jun-14-24 06:13AM	3 Blue-Chip Stocks to Triple Your Wealth by 2026: June Edition (InvestorPlace)
Jun-11-24 10:42AM	Load Up, Says Goldman Sachs About These 2 Strong Buy Stocks (TipRanks)
Jun-03-24 02:27PM	7 Overlooked Stocks Offering Long-Term Stability From the Shadows (InvestorPlace)
Jun-01-24 08:05AM	Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 (PR Newswire)
May-31-24 11:31AM	Why Is Jazz (JAZZ) Down 3.5% Since Last Earnings Report? (Zacks)
May-30-24 07:30AM	Jazz Pharmaceuticals Showcases Pioneering Research in Sleep Medicine at SLEEP 2024 (PR Newswire)
May-29-24 04:15PM	Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences (PR Newswire)
07:45AM	Zanidatamab Granted Priority Review for HER2-Positive Metastatic Biliary Tract Cancer (PR Newswire)
May-28-24 07:00AM	NodThera Announces Appointment of Daniel Swisher as Chief Executive Officer (GlobeNewswire)
May-26-24 10:09AM	3 Cannabis Stocks to Buy Now: May 2024 (InvestorPlace)
May-23-24 06:00AM	7 Blue-Chip Stocks to Buy Now: May 2024 (InvestorPlace)
May-22-24 07:01PM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research)
04:00PM	Jazz Pharmaceuticals Announces Collaboration With Life Science Cares To Improve the Wellbeing of Under Resourced Communities Through Employee Volunteerism (ACCESSWIRE)
May-17-24 02:32PM	3 Cheap Blue-Chip Stocks to Buy Now: May 2024 (InvestorPlace)
May-09-24 09:19AM	7 Cannabis Stocks to Buy for a Smoking-Hot 2024 (InvestorPlace)
May-08-24 04:30PM	The 7 Top-Selling Cannabis Companies Ranked by Revenue: Which Weed Stocks to Buy? (InvestorPlace)
01:22PM	Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-07-24 05:37PM	Jazz Pharmaceuticals Insider Sold Shares Worth $548,250, According to a Recent SEC Filing (MT Newswires)
10:57AM	Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-06-24 09:29AM	Jazz (JAZZ) International Revenue Performance Explored (Zacks)
May-03-24 12:41PM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research)
11:49AM	UBS Adjusts Price Target on Jazz Pharmaceuticals to $117 From $121, Maintains Neutral Rating (MT Newswires)
May-02-24 11:26AM	Jazz (JAZZ) Q1 Earnings & Sales Fall Short of Estimates (Zacks)
03:53AM	Jazz Pharmaceuticals Q1 Adjusted Earnings Decline, Revenue Rises; Reaffirms 2024 Outlook (MT Newswires)
May-01-24 08:56PM	JAZZ Stock Earnings: Jazz Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
07:00PM	Jazz (JAZZ) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
04:24PM	Jazz: Q1 Earnings Snapshot (Associated Press Finance)
04:10PM	Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference (PR Newswire)
04:05PM	Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance (PR Newswire)
Apr-30-24 09:50AM	Jazz Pharmaceuticals Focuses on Taking Actions To Positively Impact the Planet This Earth Month (ACCESSWIRE)
Apr-24-24 04:05PM	Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024 (PR Newswire)
10:01AM	Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
05:21AM	3 No-Brainer Stocks to Buy With $300 Right Now (Motley Fool)
Apr-23-24 11:15AM	Jazz Pharmaceuticals Employees Wear Purple To Support Epilepsy Awareness and Community (ACCESSWIRE)
Apr-17-24 04:15PM	Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024 (PR Newswire)
Apr-10-24 07:45AM	Jazz Pharmaceuticals to Showcase Expansive Neuroscience Portfolio at American Academy of Neurology Annual Meeting (PR Newswire)
Apr-04-24 09:15AM	Following the Money Trail: Where are Hedge Funds Investing? (Insider Monkey)
Apr-02-24 07:30AM	Jazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract Cancer (PR Newswire)
Mar-29-24 11:30AM	Why Is Jazz (JAZZ) Up 1.3% Since Last Earnings Report? (Zacks)
Mar-28-24 10:15AM	Cancer and the Combination Approach (ACCESSWIRE)
Mar-20-24 10:15AM	Jazz Pharmaceuticals Celebrates International Womens Day (ACCESSWIRE)
Mar-18-24 03:28PM	20 States with the Cheapest Weed in America (Insider Monkey)
Mar-17-24 08:50AM	30 Biggest Biotechnology Companies in the World (Insider Monkey)
Mar-14-24 12:00PM	Exploring How Jazz Pharmaceuticals Honored U.S. Black History Month (ACCESSWIRE)
10:00AM	Unlocking Jazz Pharmaceuticals' Potential: A Roadmap for Growth (GuruFocus.com)
Mar-13-24 02:25PM	7 Biotech Stocks to Buy as Sector Rotation Ramps Up (InvestorPlace)
Mar-12-24 05:34PM	11 Stocks Insiders are Buying Now (Insider Monkey)
04:15PM	Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024 (PR Newswire)
Mar-09-24 11:15AM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Mar-07-24 01:51PM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research)
01:10PM	Q4 2023 Zymeworks Inc Earnings Call (Thomson Reuters StreetEvents)
10:08AM	10 Mid-Cap Stocks with Insider Purchases (Insider Monkey)
Feb-29-24 10:45AM	Jazz (JAZZ) Q3 Earnings Lag, Revenues in Line With Estimates (Zacks) -8.33%
10:35AM	Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-28-24 06:30PM	Here's What Key Metrics Tell Us About Jazz (JAZZ) Q4 Earnings (Zacks)
05:20PM	Jazz Pharmaceuticals (JAZZ) Q4 Earnings Lag Estimates (Zacks)
04:33PM	Jazz Pharmaceuticals PLC (JAZZ) Reports Strong Revenue Growth and Robust Pipeline Progress (GuruFocus.com)
04:29PM	Jazz: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2023 Financial Results and Provides 2024 Financial Guidance (PR Newswire)

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Henderson Mary Elizabeth	SVP, Technical Operations	Sep 06 '24	Sale	108.30	1,410	152,703	14,531	Sep 11 11:38 AM
Henderson Mary Elizabeth	Officer	Sep 06 '24	Proposed Sale	110.00	2,691	296,010		Sep 05 07:50 PM
Winningham Rick E	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:57 PM
Smith Mark Douglas	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:55 PM
RIEDEL NORBERT G	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:49 PM
ORiordan Anne	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:42 PM
O'Keefe Kenneth W	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:35 PM
McSharry Heather Ann	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:29 PM
Cook Jennifer E.	Director	Aug 06 '24	Proposed Sale	111.00	3,075	341,325		Aug 05 09:19 PM
Sohn Catherine A.	Director	Aug 05 '24	Proposed Sale	111.00	3,075	341,325		Aug 02 04:20 PM
Carr Patricia	SVP, Chief Accounting Officer	Jun 07 '24	Sale	108.83	163	17,738	6,596	Jun 11 08:15 PM
Patil Neena M	EVP & Chief Legal Officer	May 03 '24	Sale	109.65	5,000	548,250	36,629	May 07 05:31 PM
Carr Patricia	SVP, Chief Accounting Officer	Mar 06 '24	Sale	119.64	1,936	231,628	8,364	Mar 08 06:07 PM
Carr Patricia	SVP, Chief Accounting Officer	Mar 07 '24	Sale	116.98	1,768	206,821	6,596	Mar 08 06:07 PM
Johnson Philip L	EVP & Chief Financial Officer	Mar 01 '24	Buy	119.65	12,000	1,435,800	27,932	Mar 05 07:28 PM
Smith Mark Douglas	Director	Dec 04 '23	Sale	119.27	417	49,736	6,888	Dec 06 04:39 PM
Cook Jennifer E.	Director	Dec 04 '23	Sale	119.27	417	49,736	6,888	Dec 06 04:31 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

JAZZ

Jazz Pharmaceuticals plc

Upgrade your FINVIZ experience